Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solifenacin with simplified bladder training versus solifenacin alone in overactive bladder
2005-005546-39Phase 4Completed
- Sponsor
- Astellas Pharma
- Start
- Mar 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of solifenacin in overactive bladder (OAB) (2 arms), sponsored by Astellas Pharma. Started Mar 2006; status: completed.
02
Drugs
solifenacin
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on 2005-005546-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005546-39.